Fri 25'th May 2018
Biostar Pharmaceuticals Stock Analysis
Technical stock analysis for Fri 25'th May 2018
No changes to the price of Biostar Pharmaceuticals in the last trading day. The price has fallen in 5 of the last 10 days and is down by -8.14% for this period.
|Shorts||2.23% ( 2018-04-30 )|
Biostar Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.77% during the next 3 months and, with 90% probability hold a price between $1.11 and $2.12 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday May 24, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Biostar Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.45 and $2.58. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 31 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $2.22 and $2.20.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biostar Pharmaceuticals finds support just below today's level at $2.22. If this is broken, then the next support from accumulated volume will be at $2.20 and $2.02.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 6.81%. For the last week the stock has had a daily average volatility of 5.44%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Trade BSPM CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder